INSY
Insys Therapeutics, Inc.
INSY
INSY
Delisted
INSY was delisted on the 18th of June, 2019.
103 hedge funds and large institutions have $94.2M invested in Insys Therapeutics, Inc. in 2018 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 31 increasing their positions, 21 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
103
Holders Change
-7
Holders Change %
-6.36%
% of All Funds
2.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
31
Reduced
21
Closed
20
Calls
$3.55M
Puts
$6.18M
Net Calls
-$2.63M
Net Calls Change
-$2.11M
Top Buyers
| 1 |
1
BlackRock
New York
|
$19.1M |
| 2 |
2
Millennium Management
New York
|
$1.23M |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$18.4M |
| 4 |
JG
4
Jefferies Group
New York
|
$371K |
| 5 |
5
Geode Capital Management
Boston,
Massachusetts
|
$2.18M |
